𝔖 Bobbio Scriptorium
✦   LIBER   ✦

DNA-Topoisomerase I, a new target for the treatment of neuroblastoma

✍ Scribed by G Vassal; C Pondarré; C Cappelli; M.J Terrier-Lacombe; I Boland; J Morizet; J Bénard; A.M Vénuat; P Ardouin; O Hartmann; A Gouyette

Book ID
117664003
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
64 KB
Volume
33
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New therapeutic targets for the treatmen
New therapeutic targets for the treatment of high-risk neuroblastoma
✍ Lars M. Wagner; Mary K. Danks 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

## Abstract High‐risk neuroblastoma remains a major problem in pediatric oncology, accounting for 15% of childhood cancer deaths. Although incremental improvements in outcome have been achieved with the intensification of conventional chemotherapy agents and the addition of 13‐__cis__‐retinoic acid

Effects of CPT-11 (a unique DNA topoisom
Effects of CPT-11 (a unique DNA topoisomerase I inhibitor) on a highly malignant xeno-transplanted neuroblastoma
✍ Komuro, Hiroaki ;Li, Pai ;Tsuchida, Yoshiaki ;Yokomori, Kinji ;Nakajima, Katsuyo 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 592 KB

## Abstract Although many advances have been made in the management of neuroblastoma, the prognosis of patients with advanced neuroblastoma remains poor, and constant efforts are being made to search for newer effective drugs. CPT‐11 is a newly developed derivative of camptothecin and shows a uniqu